Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christy Goldsmith

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|October 2, 2012
Stereotactic ablative body radiotherapy (SABR) for primary and secondary lung tumoursChristy Goldsmith, Andrew Gaya
Handbook of Clinical Neurology|January 11, 2012
RadiotherapyGiuseppe Minniti, Christy Goldsmith, Michael Brada
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 8, 2011
Large breast size as a risk factor for late adverse effects of breast radiotherapy: is residual dose inhomogeneity, despite 3D treatment planning and delivery, the main explanation?Christy Goldsmith, Joanne Haviland, Yat Tsang, et al.
Breast Cancer (Dove Medical Press)|June 28, 2017
An effective deep-inspiration breath-hold radiotherapy technique for left-breast cancer: impact of post-mastectomy treatment, nodal coverage, and dose schedule on organs at riskLynsey Rice, Christy Goldsmith, Melanie Ml Green, et al.
Seminars in Radiation Oncology|March 23, 2016
Dose-Volume Histogram Analysis of Stereotactic Body Radiotherapy Treatment of Pancreatic Cancer: A Focus on Duodenal Dose ConstraintsChristy Goldsmith, Patricia Price, Timothy Cross, et al.
Radiation Oncology (London, England)|October 21, 2018
Stereotactic ablative radiotherapy (SABR) as primary, adjuvant, consolidation and re-treatment option in pancreatic cancer: scope for dose escalation and lessons for toxicityChristy Goldsmith, P Nicholas Plowman, Melanie M Green, et al.
Journal of Gastrointestinal Cancer|December 10, 2008
Neuroendocrine tumour of the cystic duct: a case report and literature reviewFlora Stavridi, Heung Chong, Sam Chan, et al.
Cureus|January 17, 2019
Evaluation of CyberKnife® Fiducial Tracking Limitations to Assist Targeting Accuracy: A Phantom Study with Fiducial DisplacementChristy Goldsmith, Melanie M Green, Brownwyn Middleton, et al.
Cureus|May 29, 2018
CyberKnife Radiosurgery of Skull-base Tumors: A UK Center ExperienceHannah P Wilson, Patricia M Price, Keyoumars Ashkan, et al.
Cancer Research|March 12, 2016
Cytochrome P450 Allele CYP3A7*1C Associates with Adverse Outcomes in Chronic Lymphocytic Leukemia, Breast, and Lung CancerNichola Johnson, Paolo De Ieso, Gabriele Migliorini, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|October 2, 2012
Stereotactic ablative body radiotherapy (SABR) for primary and secondary lung tumoursChristy Goldsmith, Andrew Gaya
Handbook of Clinical Neurology|January 11, 2012
RadiotherapyGiuseppe Minniti, Christy Goldsmith, Michael Brada
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 8, 2011
Large breast size as a risk factor for late adverse effects of breast radiotherapy: is residual dose inhomogeneity, despite 3D treatment planning and delivery, the main explanation?Christy Goldsmith, Joanne Haviland, Yat Tsang, et al.
Breast Cancer (Dove Medical Press)|June 28, 2017
An effective deep-inspiration breath-hold radiotherapy technique for left-breast cancer: impact of post-mastectomy treatment, nodal coverage, and dose schedule on organs at riskLynsey Rice, Christy Goldsmith, Melanie Ml Green, et al.
Seminars in Radiation Oncology|March 23, 2016
Dose-Volume Histogram Analysis of Stereotactic Body Radiotherapy Treatment of Pancreatic Cancer: A Focus on Duodenal Dose ConstraintsChristy Goldsmith, Patricia Price, Timothy Cross, et al.
Radiation Oncology (London, England)|October 21, 2018
Stereotactic ablative radiotherapy (SABR) as primary, adjuvant, consolidation and re-treatment option in pancreatic cancer: scope for dose escalation and lessons for toxicityChristy Goldsmith, P Nicholas Plowman, Melanie M Green, et al.
Journal of Gastrointestinal Cancer|December 10, 2008
Neuroendocrine tumour of the cystic duct: a case report and literature reviewFlora Stavridi, Heung Chong, Sam Chan, et al.
Cureus|January 17, 2019
Evaluation of CyberKnife® Fiducial Tracking Limitations to Assist Targeting Accuracy: A Phantom Study with Fiducial DisplacementChristy Goldsmith, Melanie M Green, Brownwyn Middleton, et al.
Cureus|May 29, 2018
CyberKnife Radiosurgery of Skull-base Tumors: A UK Center ExperienceHannah P Wilson, Patricia M Price, Keyoumars Ashkan, et al.
Cancer Research|March 12, 2016
Cytochrome P450 Allele CYP3A7*1C Associates with Adverse Outcomes in Chronic Lymphocytic Leukemia, Breast, and Lung CancerNichola Johnson, Paolo De Ieso, Gabriele Migliorini, et al.
Pageof 1